Harvard Management Company’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,464,990
| Closed | -$138M | – | 47 |
|
|
2021
Q4 | $138M | Sell |
3,464,990
-3,677,866
| -51% | -$147M | 12.96% | 3 |
|
|
2021
Q3 | $258M | Hold |
7,142,856
| – | – | 15.13% | 2 |
|
|
2021
Q2 | $293M | Sell |
7,142,856
-3,571,428
| -33% | -$146M | 16.85% | 2 |
|
|
2021
Q1 | $467M | Sell |
10,714,284
-3,976,496
| -27% | -$173M | 26.11% | 1 |
|
|
2020
Q4 | $735M | Hold |
14,690,780
| – | – | 39.88% | 1 |
|
|
2020
Q3 | $618M | Hold |
14,690,780
| – | – | 33.99% | 1 |
|
|
2020
Q2 | $713M | Buy |
+14,690,780
| New | +$713M | 60.83% | 1 |
|